Education
About Us
Working with TipRanks
Follow Us
Bausch Health Companies (TSE:BHC)
TSX:BHC
RESEARCH TOOLSreports
Earnings Data
Report Date
Oct 30, 2025Before Open (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
1.53Last Year’s EPS
1.59Same Quarter Last Year
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflected a strong overall performance with consistent growth in key segments and strategic initiatives like the acquisition of DURECT Corporation. However, challenges such as revenue declines in the diversified segment and potential impacts from IRA negotiations were noted. Despite these issues, the company's positive growth trajectory and strategic actions suggest a favorable outlook.Company Guidance -
Q3 2025
Consistent Revenue and EBITDA Growth
Bausch Health, excluding Bausch + Lomb, reported year-over-year revenue growth of 5% and a 10% increase in adjusted EBITDA, marking nine consecutive quarters of growth in these metrics.
Successful Debt Refinancing
Completed a $7.9 billion debt refinancing, extending maturities and reducing high-interest debt, which improves the capital structure.
Strong Performance in Salix and Solta Segments
Salix revenues increased by 12%, with segment profit up 21%. Solta revenues grew by 25%, driven by a 115% increase in South Korea.
Strategic Acquisition of DURECT Corporation
Announced the acquisition of DURECT Corporation to develop treatments for alcohol hepatitis, enhancing Bausch Health's hepatology expertise.
International Growth and Product Launches
EMEA business sustained organic growth with a 6% increase, and Canada showed strong results with successful product launches like CABTREO and Ryaltris.
TSE:BHC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TSE:BHC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Jul 30, 2025 | C$8.85 | C$8.17 | -7.68% |
Apr 30, 2025 | C$7.33 | C$7.31 | -0.27% |
Feb 19, 2025 | C$9.30 | C$10.18 | +9.46% |
Oct 30, 2024 | C$11.37 | C$12.81 | +12.66% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Bausch Health Companies (TSE:BHC) report earnings?
Bausch Health Companies (TSE:BHC) is schdueled to report earning on Oct 30, 2025, Before Open (Confirmed).
What is Bausch Health Companies (TSE:BHC) earnings time?
Bausch Health Companies (TSE:BHC) earnings time is at Oct 30, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:BHC EPS forecast?
TSE:BHC EPS forecast for the fiscal quarter 2025 (Q3) is 1.53.